Differential regulation of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2 expression in co-cultures of prostate cancer and stromal cells

被引:68
作者
Dong, Z
Nemeth, JA
Cher, ML
Palmer, KC
Bright, RC
Fridman, R
机构
[1] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA
[2] Wayne State Univ, Sch Med, Dept Urol, Detroit, MI 48201 USA
[3] Barbara Ann Karmanos Canc Inst, Detroit, MI USA
关键词
matrix metalloproteinase; prostate cancer; stroma; tissue inhibitor of metalloproteinase; fibroblast;
D O I
10.1002/ijc.1358
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor-stromal interactions have been suggested to be a critical factor in both tumor invasion and tumor metastasis, Here, we examined the role of tumor-stromal interactions using co-cultures of prostate cancer (PC) cells derived from primary and metastatic tumors with primary or immortalized stromal (fibroblast and smooth muscle) cells and their effect on matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) expression. co-cultures of PC and stromal cells showed enhanced levels of pro-MMP-9 and reduced levels of TIMP-1 and TIMP-2, Whereas enhanced expression of pro-MMP-9 occurred in PC cells, the TIMPs were down-regulated in stromal cells, Induction of pro-MMP-9 and reduction of TIMP expression did not require cell-cell contact and were mediated by a soluble factor(s) present in the conditioned medium of the effector cell. Collagen I is a potent inducer of pro-MMP-9 in PC cells. Consistently, preliminary characterization of the soluble factor in the fibroblast conditioned medium revealed m.w. of approximately 100 to 250 kDa, and its effect on pro-MMP-9 expression was partly inhibited by an anti-alpha2 integrin antibody, a major collagen I receptor. Expression of pro-MMP-9 protein and mRNA was also induced in metastatic PC-3 cells grown in human fetal bone implants in SCID mice. Together, these findings demonstrate the importance of tumor-stromal interactions in the regulation of MMP and TIMP expression and their potential role in PC progression. (C) 2001 Wiley-Liss. Inc.
引用
收藏
页码:507 / 515
页数:9
相关论文
共 52 条
[1]  
Borchers AH, 1997, MOL CARCINOGEN, V19, P258, DOI 10.1002/(SICI)1098-2744(199708)19:4<258::AID-MC7>3.0.CO
[2]  
2-8
[3]   Tissue inhibitors of metalloproteinases: evolution, structure and function [J].
Brew, K ;
Dinakarpandian, D ;
Nagase, H .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2000, 1477 (1-2) :267-283
[4]  
Bright RK, 1997, CANCER RES, V57, P995
[5]  
CRAWFORD HC, 1994, INVAS METAST, V14, P234
[6]  
Curran S, 1999, J PATHOL, V189, P300, DOI 10.1002/(SICI)1096-9896(199911)189:3<300::AID-PATH456>3.0.CO
[7]  
2-C
[8]  
Duivenvoorden WCM, 1999, CLIN EXP METASTAS, V17, P27
[9]  
Farnsworth WE, 1999, PROSTATE, V38, P60
[10]  
Festuccia C, 2000, INT J CANCER, V85, P407, DOI 10.1002/(SICI)1097-0215(20000201)85:3<407::AID-IJC18>3.0.CO